Braverman ER - Search Results

1

Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?

Bowirrat A, Chen TJ, Oscar-Berman M, Madigan M, Chen AL, Bailey JA, Braverman ER, Kerner M, Giordano J, Morse S, Downs BW, Waite RL, Fornari F, Armaly Z, Blum K. Bowirrat A, et al. Among authors: braverman er. Mol Neurobiol. 2012 Apr;45(2):298-313. doi: 10.1007/s12035-012-8247-z. Epub 2012 Feb 28. Mol Neurobiol. 2012. PMID: 22371275 Free PMC article. Review.

2

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Blum K, et al. Among authors: braverman er. Pharmacogenetics. 1995 Jun;5(3):121-41. doi: 10.1097/00008571-199506000-00001. Pharmacogenetics. 1995. PMID: 7550364 Review.

3

The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes' theorem.

Blum K, Wood RC, Braverman ER, Chen TJ, Sheridan PJ. Blum K, et al. Among authors: braverman er. Funct Neurol. 1995 Jan-Feb;10(1):37-44. Funct Neurol. 1995. PMID: 7649500 Review.

4

Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal.

Blum K, Sheridan PJ, Wood R, Braverman ER. Blum K, et al. Among authors: braverman er. Eur Arch Psychiatry Clin Neurosci. 1995;245(1):50-2. doi: 10.1007/BF02191544. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 7786911 No abstract available.

5

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG, Comings DE. Blum K, et al. Among authors: braverman er. J R Soc Med. 1996 Jul;89(7):396-400. doi: 10.1177/014107689608900711. J R Soc Med. 1996. PMID: 8774539 Free PMC article. Review.

6

Substance use disorder exacerbates brain electrophysiological abnormalities in a psychiatrically-ill population.

Braverman ER, Blum K. Braverman ER, et al. Clin Electroencephalogr. 1996;27(4 Suppl):5-27. doi: 10.1177/1550059496027s0402. Clin Electroencephalogr. 1996. PMID: 8902324

7

P300 (latency) event-related potential: an accurate predictor of memory impairment.

Braverman ER, Blum K. Braverman ER, et al. Clin Electroencephalogr. 2003 Jul;34(3):124-39. doi: 10.1177/155005940303400306. Clin Electroencephalogr. 2003. PMID: 14521274 Clinical Trial.

8

Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders.

Chen TJ, Blum K, Mathews D, Fisher L, Schnautz N, Braverman ER, Schoolfield J, Downs BW, Comings DE. Chen TJ, et al. Among authors: braverman er. Med Hypotheses. 2005;65(4):703-7. doi: 10.1016/j.mehy.2005.04.037. Med Hypotheses. 2005. PMID: 15964153

9

Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting.

Braverman ER, Chen TJ, Schoolfield J, Martinez-Pons M, Arcuri V, Varshavskiy M, Gordon CA, Mengucci J, Blum SH, Meshkin B, Downs BW, Blum K. Braverman ER, et al. Adv Ther. 2006 Jul-Aug;23(4):582-600. doi: 10.1007/BF02850047. Adv Ther. 2006. PMID: 17050501

10

Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).

Blum K, Chen TJ, Meshkin B, Downs BW, Gordon CA, Blum S, Mangucci JF, Braverman ER, Arcuri V, Deutsch R, Pons MM. Blum K, et al. Among authors: braverman er. Med Hypotheses. 2007;68(4):844-52. doi: 10.1016/j.mehy.2006.08.041. Epub 2006 Oct 27. Med Hypotheses. 2007. PMID: 17071010

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page